BeiGene: BeiGene, Ltd.: BeiGene Receives Positive CHMP Opinion for TEVIMBRA as a First-Line Treatment for Extensive-Stage Small Cell Lung Cancer

Positive opinion for first-line treatment of extensive-stage small cell lung cancer based on results of RATIONALE-312 study demonstrating statistically significant overall survival benefit for TEV...